Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
223.1 USD | +0.01% | -2.34% | -5.64% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 11.49B | |
+41.79% | 54.04B | |
+45.77% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Citigroup Adjusts Price Target on Charles River Laboratories to $215 From $190, Keeps Neutral Rating